Tuesday, February 14, 2023

Ryne Biotechnology Snags $4M Grant

San Diego-based Ryne Biotechnology, a company developing stem cell technology to treat neurological disorders, says it has received a $4M grant from the California Institute for Regenerative Medicine (CIRM). The company said it will use the funding advance its lead candidate RNDP-001, an iPSC-derived dopamine neuron progenitor for the treatment of both inherited and idiopathic forms of Parkinson’s disease, through submission of an Investigational New Drug (IND) application. Nick Manusos is CEO of Ryne Bio.